期刊文献+

Predictors to assess non-sentinel lymph node status in breast cancer patients with only one sentinel lymph node metastasis 被引量:17

Predictors to assess non-sentinel lymph node status in breast cancer patients with only one sentinel lymph node metastasis
原文传递
导出
摘要 Background The purpose of this study was to investigate the feasibility of avoiding axillary lymph node dissection (ALND) for patients with only one sentinel lymph node (SLN) metastasis. The characteristics and predictive factors for non-sentinel lymph node (NSLN) metastasis of patients with single positive SLN were also analyzed. Methods Patients with no and only one SLN metastasis (OIn and 1In group, n ≥2) were selected from 1228 cases of invasive breast carcinoma, who underwent axillary dissection in Shandong Cancer Hospital between November 1999 and December 2011, to compare the characteristics of NSLN metastasis between them. For the 1In group, the factors that influenced the NSLN metastasis were analyzed by univariate and multivariate analysis. Results Differences of the NSLN metastasis between the OIn and the 1In groups were significant (P 〈0.001). There was no significant difference between the axillary lymph node metastasis on level III in 1In group and OIn group (P=0.570). When the total SLN number was 〉4 and with one positive case, the NSLN metastasis was not significantly different from that in the OIn group (P=-0.118). In the 1In group, clinical tumor size (P = 0.012), over-expression of Her-2 (P=0.003), tumor grade (P=0.018) and the total number of SLN (P=0.047) significantly correlated with non-SLN metastasis. Clinical tumor size (P=0.015) and the expression of Her-2 (P=0.01) were independent predictive factors for non-SLN metastasis by the Logistic regression model. Conclusion Under certain conditions, breast cancer patients with single SLN metastasis could avoid ALND. Background The purpose of this study was to investigate the feasibility of avoiding axillary lymph node dissection (ALND) for patients with only one sentinel lymph node (SLN) metastasis. The characteristics and predictive factors for non-sentinel lymph node (NSLN) metastasis of patients with single positive SLN were also analyzed. Methods Patients with no and only one SLN metastasis (OIn and 1In group, n ≥2) were selected from 1228 cases of invasive breast carcinoma, who underwent axillary dissection in Shandong Cancer Hospital between November 1999 and December 2011, to compare the characteristics of NSLN metastasis between them. For the 1In group, the factors that influenced the NSLN metastasis were analyzed by univariate and multivariate analysis. Results Differences of the NSLN metastasis between the OIn and the 1In groups were significant (P 〈0.001). There was no significant difference between the axillary lymph node metastasis on level III in 1In group and OIn group (P=0.570). When the total SLN number was 〉4 and with one positive case, the NSLN metastasis was not significantly different from that in the OIn group (P=-0.118). In the 1In group, clinical tumor size (P = 0.012), over-expression of Her-2 (P=0.003), tumor grade (P=0.018) and the total number of SLN (P=0.047) significantly correlated with non-SLN metastasis. Clinical tumor size (P=0.015) and the expression of Her-2 (P=0.01) were independent predictive factors for non-SLN metastasis by the Logistic regression model. Conclusion Under certain conditions, breast cancer patients with single SLN metastasis could avoid ALND.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第3期476-481,共6页 中华医学杂志(英文版)
关键词 breast neoplasms sentinel lymph node BIOPSY non-sentinel lymph node lymphatic metastasis breast neoplasms, sentinel lymph node, biopsy, non-sentinel lymph node, lymphatic metastasis
  • 相关文献

参考文献1

二级参考文献13

  • 1任淑华,王井伟,张林.Her-2/neu小分子干扰RNA对肺腺癌细胞周期和凋亡机制的影响[J].中华医学杂志,2005,85(22):1530-1534. 被引量:3
  • 2许良中.预后的生物学标记[A].见:许良中主编.乳腺病理学[M].上海:上海医科大学出版社,1999.359.
  • 3Joukov V,Sarsa T,Kumar V,et al.Proteolytic processing regulates receptor specificity and activity of VEGF-C.EMBO J,1997,16:3898-3911.
  • 4Schmid-Schonbein GW.Microlymphatics and lymph flow.Physiol Rev,1990,70:987-1028.
  • 5Ross JS,Fletcher JA.HER-2/neu (c-erb-B2) gene and protein in breast cancer.Am J Clin Pathol,1999,112:53-67.
  • 6Jussila L,Alitalo K Vascular growth factors and lymphangiogenesis.Physiol Rev,2002,82:673-700.
  • 7Nathanson SD.Insights into the mechanisms of lymph node metastasis.Cancer,2003,98:413-423.
  • 8Tsai PW,Shiah SG,Lin MT,et al.Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta1.A critical role of p38/nuclear factor-kappa B signaling pathway.J Biol Chem,2003,21,278:5750-5759.
  • 9Yang W,Klos K,Yang Y,et al.ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A,C and D in human breast carcinoma.Cancer,2002,94:2855-2861.
  • 10Shak S.Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer.Herceptin Multinational Investigator Study Group.Semin Oncol,1999,26:71-77.

共引文献4

同被引文献59

引证文献17

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部